Highlights
NASDAQ: EGRX       Eagle Pharmaceutical
Last Price Today's Change   Day's Range   Trading Volume
56.95   0.00 (0.00%)  0.00 - 0.00  0

Overview

 
Avg Volume (4 weeks):283,795
4 Weeks Range:51.68 - 63.67
4 Weeks Price Volatility (%):
89.45%
52 Weeks Range:45.05 - 97.15
52 Weeks Price Volatility (%):
58.62%
Average Price Target: 65.00
Price Target Upside/Downside: +8.05

Headlines



No recent Headlines for this stock.


Business Background

Eagle Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company focuses on developing and commercializing injectable products in the critical care and oncology areas. The Company's product portfolio includes products, including Argatroban; Ryanodex; docetaxel injection, non-alcohol formulation; and Bendeka. Its advanced candidates include EP-3101 (bendamustine Resistance Temperature Detectors (RTD)) (EP-3101), EP-4104 (dantrolene sodium for exertional heat stroke (EHS)) (EP-4104), EGL-4104-C-1702 (dantrolene sodium for drug induced hyperthermia), EP-5101 (pemetrexed) (EP-5101) and EGL-5385-C-1701 (fulvestrant). Its product portfolio focuses on oncology, critical care and orphan diseases. Bendamustine is an alkylating agent approved for use in chronic lymphocytic leukemia (CLL), and indolent B-cell non-Hodgkin's lymphoma (NHL), that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen.

  Be the first to like this.
 


 

8485 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 RHE 0.270.00 
 HONE 19.170.00 
 EPHE 37.330.00 
 ENZL 45.000.00 
 FTRPR 12.920.00 
 ABEOW 11.210.00 
 UBIO 30.890.00 
 CIGI 61.950.00 
 IMU.W 0.050.00 
 ESXB 8.400.00 
Partners & Brokers